Drug Information Association Logo
Corporate Tagline

8th Annual European Medical Information and Communications Conference

Sep 23 2014 9:00AM - Sep 24 2014 5:30PM | Millennium Gloucester Hotel London Kensington 4-18 Harrington Gardens London SW7 4LH United Kingdom

« Back to Listing

Overview 

Up until now, the DIA European Medical Information and Communications Conference has taken place as part of the Annual DIA Clinical Forum. After several years of continued success with growing attendance and excellent feedback, DIA is organising this event as a standalone meeting in 2014.
Every year, opinion leaders from departments for Medical Information, Medical and Scientific Communication and Medical Affairs gather to share hands-on experience, get up to speed on new technologies and best practices, and network. Join this annual event to connect to and become part of an elite group of professionals, build long lasting professional relationships that will greatly benefit your career.

What attendees from 2013 said
“Great, extensive knowledge & put across in an engaging useful way.”
“Good to share company experience.”
“Very relevant topics!”
“Going home with some great ideas to share!”

Who Should Attend 

  • Industry and Academia
  • Regulatory Authorities/Government Agencies
  • Professionals involved in:
    • Medical Information
    • Medical Communications
    • Medical Affairs

Learning Objectives 

  • To offer a neutral platform for professionals to share operational best practices and discuss how  evolving business, regulatory and legal requirements impact the practice of medical information
  • To provide opportunities for medical information departments to showcase success stories or stories to learn by, in the popular Putting Theory into Practice session
  • To explore the impact of new technologies on information delivery and customer interactions

 

Hotel & Travel 

Millennium Gloucester Hotel London Kensington
A limited number of rooms are available at a special rate. DIA rate is guaranteed until 11 August 2014, or until room block is filled. Attendees should make reservations as soon as possible.

To make your booking, go to www.millenniumhotels.co.uk/millenniumgloucester/
Booking Code: LOND230914 (insert the code into the Enter Code box)
Single GBP 140.00/Double GBP 150.00 including breakfast and VAT

Address: 4-18 Harrington Gardens, London SW7 4LH, UK
Tel:  +44(0) 207 331 6105 Fax: +44(0) 207 331 6123

Travel Information
For details on public transport please visit http://www.tfl.gov.uk

Contact Information 

Registration Questions
Phone.: +41 61 225 51 51
Fax: +41 61 225 51 52
Monday-Friday 8:00-17:00 CET
diaeurope@diaeurope.org

Agenda and Event Logistics
Nicole Hintersatz, Event Manager
Phone: +41 61 225 51 60
Fax: +41 61 225 51 52
nicole.hintersatz@diaeurope.org

Program Committee 

Previous Next

Agenda  

Day 1 Tuesday, Sep 23, 2014

  • 8:00AM - 9:00AM (Greenwich Standard Time)

    REGISTRATION AND WELCOME COFFEE
  • 9:00AM - 9:15AM (Greenwich Standard Time)

    WELCOME TO THE CONFERENCE


    Session Chair(s):

    • No-image Lillian Auberson, PhD
      Senior Director, Global Medical Information
      Novartis Pharma AG, Switzerland
  • 9:15AM - 10:30AM (Greenwich Standard Time)

    INSIGHTS


    Session Chair(s):

    • Isabelle Catherine Widmer, DrMed
      Consultant
      elytra gmbh, Switzerland

    Insights from data analysis lie at the heart of business strategy. Historically, data was paper- based, filed by department and hard to assess. Despite an evolution to electronic data storage, departments still focus on customized department-centric analyses. This narrow focus represents a loss of value for companies, as holistic insight is not gained across a drug or family of compounds. Too often, medical information has been used only to identify FAQs or need for standard response documents. This session will focus on the wealth of medical information data and the value of that information beyond the medical information department. We will explore how sharing medical information insights with other departments can improve information provided to physicians, benefiting patients and influencing how our companies are perceived. We will demonstrate how an intelligent approach to using medical information insights can improve the value of all educational materials. We will discuss how to drive the perception of medical information, how to initiate conversations with peers in other departments, and how to show medical information as a critical business partner. Finally we will speak about how big data may influence medical information departments and the business in the future. Our goal is to demonstrate how to use insights gained in medical informtaion departments across the business to best address customer needs.

    Speaker(s):

    • Insight from Unmet Needs: The role of medical information
      Lucia Fantini
      Global Medical Information Tech Lead, ACE Region
      Eli Lilly and Company, Italy
    • Data Visualization and Dashboards in Medical Information
      Georgios Koumakis
      Medical Information Manager
      Roche Hellas, Greece
    • How big Data is Transforming Medical Information Insights
      Daniel Ghinn
      Director of Digital Engagement
      Creation Healthcare, United Kingdom
  • 10:30AM - 11:00AM (Greenwich Standard Time)

    COFFEE BREAK
  • 11:00AM - 12:30PM (Greenwich Standard Time)

    Session 2: USE OF GLOBAL CONTENT: US, EUROPEAN AND COUNTRY PERSPECTIVES


    Session Chair(s):

    • Ainhoa del Romero
      Amgen (EUROPE) GmbH, Switzerland

    Speaker(s):

    • Differences in the provision of Medical Information across EMEA – Results of an international survey
      Natalie Hanna
      Senior Medical Information Scientist - EMEA
      Eisai Europe Ltd., United Kingdom
    • US Perspectives on Authoring Global Standard Medical Response Documents - Lessons learned
      Lesley S. Fierro, PharmD, MS, RPh
      Associate Vice President, Medical Information Services
      Sanofi US , United States
    • Country Perspective
      Sabine Lischka-Wittmann
      Senior Manager, Medical Information & Medical Liaison
      Lilly Deutschland GmbH, Germany
  • 12:30PM - 2:00PM (Greenwich Standard Time)

    LUNCH
  • 2:00PM - 3:30PM (Greenwich Standard Time)

    Session 3: COMMUNICATING YOUR VALUE WORKSHOP


    Session Chair(s):

    • Sharon Leighton, PhD
      Consultant
      Sharon Leighton Consultancy Ltd., United Kingdom

    Finding ways to identify and communicate the value that medical information brings to our customers and stakeholders continues to be a hot topic. Building on from the successful 2013 session, where we approached the topic in a light-hearted fashion, this year we will specifically focus on Medical Information examples. Michelle Bridenbaker, Amgen, Switzerland, will be facilitating this participative workshop

    Speaker(s):

    • Michelle Bridenbaker
      Medical Information Senior Manager
      Amgen (europe) Gmbh, Switzerland
  • 3:30PM - 4:00PM (Greenwich Standard Time)

    COFFEE BREAK
  • 4:00PM - 5:30PM (Greenwich Standard Time)

    Session 4: TRANSPARENCY AND COMPLIANCE


    Session Chair(s):

    • No-image Janet E. Davies, MPharm
      Director, Medical Information & Medical Affairs Project Management, EMEA + Asia
      Gilead Sciences, United Kingdom

    Transparency is a key issue for organisations in today’s world. It is a particularly topical issue for the pharmaceutical industry and regulatory authorities, with increasing pressure to make more information available in the public domain. Transparency is an important part of the process of bringing new, innovative medicines to the marketplace and in ensuring collaboration between all stakeholders. It is also a critical factor in the perception of organisations by the public and the media. How transparent should we be, and how relevant is the information that will be shared? How does transparency fit with the need for compliance? In this session we will explore the theme of transparency and what it means in the context of data sharing. We will also explore issues around dissemination of information and compliance with regulations.

    Speaker(s):

    • How Transparent are the Competent Authorities? Are they transparent enough? Is the information provided relevant?
      Diederick Slijkerman
      Head of Policy, Governance and Regulatory Affairs
      Medicines Evaluation Board, Netherlands
    • Internal Audit Findings and Learnings
      Ranjana Khanna
      Head of Pharmacovigilance Quality Assurance
      Vifor Ltd, Switzerland
  • 5:30PM - 6:30PM (Greenwich Standard Time)

    NETWORKING RECEPTION AND POSTER SESSION IN THE EXHIBITION AREA

Day 2 Wednesday, Sep 24, 2014

  • 9:00AM - 10:30AM (Greenwich Standard Time)

    Session 5: IN AND OUT-SOURCING MODELS


    Session Chair(s):

    • Sangeetha Anand, PhD, MS
      Senior Manager - Global Medical Information
      Vifor Pharma Ltd, Switzerland

    A much debated but insightful topic is about sourcing models in support of medical information. Given the current state of industry wide budget cuts, outsourcing medical information services has become the norm rather than the exception. This session would attempt to shed light on the quality aspect of one company model that has chosen to outsource its contact centre activities. Presentations will feature the pros and cons of outsourcing, with regard to the quality, time, cost savings as well as the cultural fit in an outsourced model. Juxtaposing the above will be a presentation that would aim to drive the value of retaining medical information deliverables in-house. The session will end with a panel discussion wherein the state of medical information outsourcing and insourcing experiences will be shared. A panel of medical information industry experts will provide their perspective on why they have gone about shoring medical information services abroad as well as those that have decided to bring these outsourced services right back into the company.
    The session will be followed by a panel discussion and Q&A with session speakers and Joanne Gibson, MCI Team Lead, Director, Pfizer EMEA Medical Information, UK

    Speaker(s):

    • Outsourcing Med-Info Contact Centre Activities
      Ros O'Callaghan, MPharm
      Director, Medical Information EU
      Bristol Meyes Squibb UK, United Kingdom
    • The Value of Keeping Medical Information In-House
      Philip Ball
      Market Access Brand Manager – Analgesics
      Napp Pharmaceutical Group Ltd, United Kingdom

    Discussant(s):

    • Joanne Gibson, RN
      MCI Team Lead; Director
      Pfizer EMEA Medical Information, United Kingdom
  • 10:30AM - 11:00AM (Greenwich Standard Time)

    COFFEE BREAK
  • 11:00AM - 12:30PM (Greenwich Standard Time)

    Session 6: INFORMATION TO PATIENTS IN THE EUROPEAN UNION


    Session Chair(s):

    • No-image Lillian Auberson, PhD
      Senior Director, Global Medical Information
      Novartis Pharma AG, Switzerland

    This session will cover the latest developments on information to patients and healthcare professionals in the European Union. It will also include observations from research on effective information presentation in Risk Management Plan Summaries and conveying benefit information to patients about medicines.

    Speaker(s):

    • Information to Patients and Healthcare Professionals: Update from the EMA
      Juan Garcia Burgos
      Scientific Administrator
      European Medicines Agency, United Kingdom
    • Risk Management Plan Lay Summaries - How to Make them fit-for-purpose
      D.K.Theo Raynor, PhD, MPharm
      Professor of Pharmacy Practice
      University of Leeds, United Kingdom
    • Providing Benefit Information in Patient Leaflets - Can it be done and what do Patients think?
      (on behalf of Rebecca Dickinson, Lecturer, School of Healthcare, University of Leeds, UK)
      Representative Invited
      Head, Patient Information Quality
      MHRA
  • 12:30PM - 2:00PM (Greenwich Standard Time)

    LUNCH
  • 2:00PM - 3:30PM (Greenwich Standard Time)

    Session 7: THE FUTURE OF MEDICAL INFORMATION


    Session Chair(s):

    • No-image Aaron Cockell, MBA
      Medical Information Regional Director, EMEA
      Pfizer Ltd, United Kingdom

    The term “digital omnivore” has been used to define physicians and practitioners who use the combination of three “screens”: smart phone, tablet and desktop/laptop computers.* This means that, in creating content, medical information departments will need to consider this new way of consuming information provided. This session will explore opportunities in the digital age and operational considerations. *Epocrates 2013 Mobile Trends Report

    Speaker(s):

    • One Standard Response Fits All?! Serving multiple channels in compliance – a 1½ year experience
      Marie-Luise Helmich, PharmD
      Medical Director
      Sanofi-Aventis Deutschland GmbH, Germany
    • The digital world and the future of medical information
      Myrto Lee
      Senior Manager
      PricewaterhouseCoopers, United Kingdom
  • 3:30PM - 4:00PM (Greenwich Standard Time)

    COFFEE BREAK
  • 4:00PM - 5:30PM (Greenwich Standard Time)

    Session 8: PUTTING THEORY INTO PRACTICE


    Session Chair(s):

    • Sarah Dunnett
      Senior Medical Affairs Manager
      Baxter Healthcare Ltd., United Kingdom

    During this dynamic session, we will gain valuable insights to a diverse range of five initiatives from across our MI network. MI professionals will share their first-hand experiences in overcoming specific challenges, applying novel technology solutions and advancing their teams and processes to deliver even greater value for their companies and, of course, for patients. Our speakers will share the highs and lows of their project pathways and their learnings along the way.

    Speaker(s):

    • Experiences of UK Medical Information Departments in PV Audits and Inspections
      Jayne Packham
      Managing Director
      Jayne Packham Consultancy Ltd., United Kingdom
    • A Regional Approach to the MI Copy Approval Process – Leaner, Better, Faster, Stronger?
      Celia Wilson
      Senior EMEA Medical Information Scientist
      Eisai Europe Ltd., United Kingdom
    • Building Synergy between Global Medical Information and the Affiliates: A critical success factor to achieve the same goals
      Emilie Coutanson, PharmD
      Global Scientific Information Project Manager
      Actelion Pharmaceuticals Ltd., Switzerland
    • GeMINi: Growth of Medical Information in Middle East, North Africa and French West Africa under the Lead of Egypt
      Shaymaa Mady
      Medical Information and Scientific Communication Manager
      Novartis, Egypt
    • Medical Information Ready for Launch
      Christine Kleemann
      Medical Information Country Lead Germany
      Bristol-Myers Squibb GmbH & Co. KGaA , Germany

Exhibits  

A limited number of booths are available for very targeted exhibiting!

Download Application Form

For more information please contact: Roxann Schumacher, DIA Exhibition Manager
on +41 61 225 51 38 or email:
roxann.schumacher@diaeurope.org

  • Aris Global
  • EXPLORIA SPS LLC
  • MakroCare / PharmCentre
  • Mavens Consulting
  • Online Business Application
  • PharmaReview Ltd
  • PI ARM
  • PPD
  • PrimeVigilance Ltd.
  • TechSol Corporation

Registration Fees 

Member

Member Academia
€710.00
Member Government
€710.00
Member Standard
€1420.00

Non-Member

NonMember Academia
€840.00
NonMember Government
€840.00
NonMember Standard
€1550.00
Register Online
« Back to Listing Back To Top